<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01884805</url>
  </required_header>
  <id_info>
    <org_study_id>12 483 03</org_study_id>
    <nct_id>NCT01884805</nct_id>
  </id_info>
  <brief_title>Feasibility of Measurement of Optical Aberrations in Hyperopia by Using an Adaptive Optics Visual Simulator (AOVIS-I)</brief_title>
  <acronym>HyperVOPTICA</acronym>
  <official_title>Feasibility of Measurement of Optical Aberrations in Hyperopia by Using an Adaptive Optics Visual Simulator (AOVIS-I)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Toulouse</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Centre de Référence National du Kératocône</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Toulouse</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary purpose of the protocol is to evaluate the adaptive optics visual simulator to
      measure optical aberrations in hyperopic eyes.

      The study hypotheses are the:

        -  Ability to measure optical aberrations in hypermetropia.

        -  Knowledge of optical aberrations of the eye hyperopic.

        -  To adapt therapeutic management in optical aberrations measured.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The procedure is guided by the custom made software and its graphical user interface. The
      interface has been designed to be user-friendly, being very similar to the software usually
      managed by the clinicians in their daily professional practice. The complete procedure in one
      patient takes less than 5 minutes and is completely non-invasive. The optical measurements
      only involve the use of low power infrared laser and the visual testing is as simple for the
      patients as watching television and making responses.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2013</start_date>
  <completion_date type="Anticipated">September 2016</completion_date>
  <primary_completion_date type="Anticipated">September 2016</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Measurement of optical aberrations</measure>
    <time_frame>1 day (Participants will be followed for the duration of ophtalmology consultation)</time_frame>
    <description>Feasibility of Measurement of optical aberrations in hyperopia by using an Adaptive Optics Visual Simulator AOVIS-I. Outcome measure is assessed during a consultation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Reproductibility of the measures</measure>
    <time_frame>1 day (Participants will be followed for the duration of ophtalmology consultation)</time_frame>
    <description>Evaluate the reproducibility of the measures obtained in hyperopic eyes. Outcome measure is assessed during a consultation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quantitative measurement of optical aberrations</measure>
    <time_frame>1 day (Participants will be followed for the duration of ophtalmology consultation)</time_frame>
    <description>Expression of optical aberrations in numerical measures. Outcome measure is assessed during a consultation</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Hyperopia</condition>
  <arm_group>
    <arm_group_label>Monocular Adaptive Optics Visual Simulator (AOVIS-I)</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Monocular Adaptive Optics Visual Simulator (AOVIS-I)</intervention_name>
    <description>The procedure is guided by the custom made software and its graphical user interface. The interface has been designed to be user-friendly, being very similar to the software usually managed by the clinicians in their daily professional practice. The complete procedure in one patient takes less than 5 minutes and is completely non-invasive. The optical measurements only involve the use of low power infrared laser and the visual testing is as simple for the patients as watching television and making responses.</description>
    <arm_group_label>Monocular Adaptive Optics Visual Simulator (AOVIS-I)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  hyperopic patients

          -  to be able to understand an information and give a consent

          -  affiliated to medical insurance

        Exclusion Criteria:

          -  pregnant women or nursing mothers

          -  ocular infection

          -  keratitis

          -  restless patients

          -  ocular surgery 90 days before inclusion
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>François MALECAZE, PHD</last_name>
    <role>Principal Investigator</role>
  </overall_official>
  <overall_contact>
    <last_name>François MALECAZE, PHD</last_name>
    <phone>05 61 77 77 52</phone>
    <phone_ext>33</phone_ext>
    <email>malecaze.fr@chu-toulouse.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Pierre FOURNIE, PHD</last_name>
    <phone>05 61 77 77 52</phone>
    <phone_ext>33</phone_ext>
    <email>fournie.p@chu-toulouse.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital, Toulouse</name>
      <address>
        <city>Toulouse</city>
        <state>Midi-Pyrenees</state>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>François MALECAZE, PHD</last_name>
      <phone>05 61 77 77 52</phone>
      <phone_ext>33</phone_ext>
      <email>malecaze.fr@chu-toulouse.fr</email>
    </contact>
    <contact_backup>
      <last_name>Pierre FOURNIE, PHD</last_name>
      <phone>05 61 77 77 52</phone>
      <phone_ext>33</phone_ext>
      <email>fournie.p@chu-toulouse.fr</email>
    </contact_backup>
    <investigator>
      <last_name>François MALECAZE, PHD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pierre FOURNIE, PHD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Céline GUILLAUD, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Fernández EJ, Manzanera S, Piers P, Artal P. Adaptive optics visual simulator. J Refract Surg. 2002 Sep-Oct;18(5):S634-8.</citation>
    <PMID>12361172</PMID>
  </reference>
  <reference>
    <citation>Piers PA, Fernandez EJ, Manzanera S, Norrby S, Artal P. Adaptive optics simulation of intraocular lenses with modified spherical aberration. Invest Ophthalmol Vis Sci. 2004 Dec;45(12):4601-10.</citation>
    <PMID>15557473</PMID>
  </reference>
  <reference>
    <citation>Piers PA, Manzanera S, Prieto PM, Gorceix N, Artal P. Use of adaptive optics to determine the optimal ocular spherical aberration. J Cataract Refract Surg. 2007 Oct;33(10):1721-6.</citation>
    <PMID>17889766</PMID>
  </reference>
  <reference>
    <citation>Manzanera S, Prieto PM, Ayala DB, Lindacher JM, Artal P. Liquid crystal Adaptive Optics Visual Simulator: Application to testing and design of ophthalmic optical elements. Opt Express. 2007 Nov 26;15(24):16177-88.</citation>
    <PMID>19550905</PMID>
  </reference>
  <reference>
    <citation>Villegas EA, Alcón E, Artal P. Optical quality of the eye in subjects with normal and excellent visual acuity. Invest Ophthalmol Vis Sci. 2008 Oct;49(10):4688-96. doi: 10.1167/iovs.08-2316. Epub 2008 Jun 14.</citation>
    <PMID>18552387</PMID>
  </reference>
  <reference>
    <citation>Fernández EJ, Prieto PM, Artal P. Wave-aberration control with a liquid crystal on silicon (LCOS) spatial phase modulator. Opt Express. 2009 Jun 22;17(13):11013-25.</citation>
    <PMID>19550501</PMID>
  </reference>
  <reference>
    <citation>Fernández EJ, Prieto PM, Artal P. Binocular adaptive optics visual simulator. Opt Lett. 2009 Sep 1;34(17):2628-30. doi: 10.1364/OL.34.002628.</citation>
    <PMID>19724513</PMID>
  </reference>
  <reference>
    <citation>Pérez GM, Manzanera S, Artal P. Impact of scattering and spherical aberration in contrast sensitivity. J Vis. 2009 Mar 25;9(3):19.1-10. doi: 10.1167/9.3.19.</citation>
    <PMID>19757958</PMID>
  </reference>
  <reference>
    <citation>Bueno JM, Acosta E, Schwarz C, Artal P. Wavefront measurements of phase plates combining a point-diffraction interferometer and a Hartmann-Shack sensor. Appl Opt. 2010 Jan 20;49(3):450-6. doi: 10.1364/AO.49.000450.</citation>
    <PMID>20090810</PMID>
  </reference>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 24, 2013</study_first_submitted>
  <study_first_submitted_qc>June 21, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 24, 2013</study_first_posted>
  <last_update_submitted>May 6, 2016</last_update_submitted>
  <last_update_submitted_qc>May 6, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 9, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Adaptive Optics Visual Simulator</keyword>
  <keyword>Wavefront aberrometer</keyword>
  <keyword>Optical Aberrations</keyword>
  <keyword>Hyperopia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperopia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

